Frontlight ResearchEarly access
Trial site
Peninsula & South Eastern Haematology and Oncology Group
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer9 trials
- Head and neck cancer3 trials
- Bladder cancer2 trials
- Gastric and oesophageal cancer2 trials
- Melanoma2 trials
- Pancreatic cancer2 trials
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Kidney cancer1 trial
- Mesothelioma1 trial
- Ovarian cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 1/24 trials
- Phase 23 trials
- Phase 33 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- BioNTech SE3 trials
- Akeso1 trial
- Ariad Pharmaceuticals1 trial
- Aulos Bioscience, Inc.1 trial
- Gilead Sciences1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Head and neck cancer3 recruiting
- Melanoma2 recruiting
- Bladder cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Pancreatic cancer1 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Completed
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026